高流量鼻导管可降低毛细支气管炎患儿的呼吸做功,但并非持续通过呼气末正压实现
这项前瞻性单中心研究纳入22例3岁及以下毛细支气管炎患儿(其中10例接受食管测压),将高流量鼻导管流量从0.5 L/kg/min逐步滴定至2 L/kg/min,用电阻抗断层成像测量呼气末肺阻抗(EELZ,作为呼气末肺容积替代指标)和潮气阻抗差(ΔZ,作为潮气量替代指标)。结果:EELZ中位数在1、1.5、2 L/kg/min时分别较0.5 L/kg/min增加0.36、2.42、4.8 AU(2 L/kg/min vs 0.5 L/kg/min,P=0.01),对应呼气末肺容积中位数增加1.8 mL/kg;潮气量无变化(中位变化0.29 AU,P=0.48);压力速率乘积中位数降低78 cm H2O/min(P=0.02),所有患者均降低,而食管压变化无显著变化(P=0.68)。作者认为,呼气末正压可能不是高流量鼻导管在毛细支气管炎患儿中的主要作用机制。
要点
- 毛细支气管炎患儿高流量鼻导管从0.5滴定至2 L/kg/min,压力速率乘积中位数降低78 cm H2O/min(P=0.02),所有患者均降低。
- 呼气末肺阻抗中位数在1、1.5、2 L/kg/min时分别较0.5 L/kg/min增加0.36、2.42、4.8 AU(P=0.01),对应呼气末肺容积中位数增加1.8 mL/kg。
- 呼气末肺阻抗变化不一致:7例增加>5 AU,12例无变化(±5 AU),3例降低>5 AU。
- 潮气量替代指标ΔZ从0.5到2 L/kg/min无变化(中位变化0.29 AU,P=0.48),食管压变化无显著变化(P=0.68)。
- 作者认为,呼气末正压可能不是高流量鼻导管在毛细支气管炎患儿中的主要作用机制。
适用人群与场景
- 3岁及以下毛细支气管炎患儿,2020年1月至2021年3月单中心前瞻性研究。
- 共22例,其中10例接受食管测压。
处置流程与药物剂量
- 高流量鼻导管流量在0.5至2 L/kg/min之间滴定;测量值报告为与0.5 L/kg/min的差值。
研究设计与关键结果
- 前瞻性单中心研究,22例毛细支气管炎患儿(10例食管测压),高流量鼻导管流量0.5–2 L/kg/min滴定。
- 呼气末肺阻抗中位数在1、1.5、2 L/kg/min时分别较0.5 L/kg/min增加0.36、2.42、4.8 AU(2 L/kg/min vs 0.5 L/kg/min,P=0.01),对应呼气末肺容积中位数增加1.8 mL/kg(0.5至2 L/kg/min)。
- 呼气末肺阻抗变化不一致:7例增加>5 AU,12例无变化(±5 AU),3例降低>5 AU。
- 潮气量替代指标ΔZ从0.5到2 L/kg/min无变化(中位变化0.29 AU,P=0.48)。
- 压力速率乘积中位数从0.5到2 L/kg/min降低78 cm H2O/min(P=0.02),所有患者均降低;食管压变化无显著变化(P=0.68)。
证据类型、等级与局限
- 前瞻性单中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,呼气末正压可能不是高流量鼻导管在毛细支气管炎患儿中的主要作用机制。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: High-flow nasal cannula (HFNC) therapy reduces the effort of breathing in patients with bronchiolitis, but the mechanisms are not understood. Theorized mechanisms include dead space washout and positive end-expiratory pressure (PEEP) application.
RESEARCH QUESTION: What are the mechanisms of action of HFNC therapy in patients with bronchiolitis?
STUDY DESIGN AND METHODS: Prospective, single-center study of children 3 years of age or younger with bronchiolitis from January 2020 through March 2021. Flow was titrated between 0.5 and 2 L/kg/min. Electrical impedance tomography measured end-expiratory lung impedance (EELZ) change as an end-expiratory lung volume (EELV) change surrogate and change in tidal impedance difference (ΔZ) as a tidal volume (VT) surrogate. A subset showed manometry measuring esophageal pressure change (ΔPes; transpulmonary pressure surrogate) and pressure rate product (PRP; effort of breathing metric). We hypothesized that EELV and VT would not change and that effort would reduce via respiratory rate (not ΔPes). Measurements were reported as the difference from 0.5 L/kg/min.
RESULTS: We studied 22 patients in total, 10 with esophageal manometry. Median EELZ increased by 0.36 arbitrary unit (AU), 2.42 AU, and 4.8 AU at 1 L/kg/min, 1.5 L/kg/min, and 2 L/kg/min (P = .01, 2 L/kg/min vs 0.5 L/kg/min), which corresponded to a median increase in EELV of 1.8 mL/kg between 0.5 and 2 L/kg/min. Seven patients showed an increase in EELZ of > 5 AU, 12 showed no change in EELZ (± 5 AU), and three showed a decrease in EELZ of > 5 AU. ΔZ (ie, VT) did not change from 0.5 L/kg/min to 2 L/kg/min (median change, 0.29 AU; P = .48). Median PRP decreased by 78 cm H2O/min from 0.5 L/kg/min to 2 L/kg/min (P = .02), with all patients demonstrating a reduction in PRP, with a nonsignificant change in ΔPes (P = .68).
INTERPRETATION: Increasing HFNC in children with bronchiolitis reduces the effort of breathing, but no consistent increase occurs in end-expiratory lung volume and no significant change occurs in VT or transpulmonary pressure. This suggests that PEEP application is not the primary mechanism of action of HFNC in children with bronchiolitis.
参考来源
- Guglielmo RD, Hotz JC, Ross PA, et al. High-Flow Nasal Cannula Reduces Effort of Breathing But Not Consistently via Positive End-Expiratory Pressure. Chest. 2022. PMID: 35305971. doi:10.1016/j.chest.2022.03.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。